# Different applications of isosbestic points, normalized spectra and dual wavelength as powerful tools for resolution of multicomponent mixtures with severely overlapping spectra

- Ekram H. Mohamed
^{1}Email author, - Hayam M. Lotfy
^{3}, - Maha A. Hegazy
^{2}and - Shereen Mowaka
^{1, 4}

**Received: **7 September 2016

**Accepted: **12 May 2017

**Published: **25 May 2017

## Abstract

### Background

Analysis of complex mixture containing three or more components represented a challenge for analysts. New smart spectrophotometric methods have been recently evolved with no limitation. A study of different novel and smart spectrophotometric techniques for resolution of severely overlapping spectra were presented in this work utilizing isosbestic points present in different absorption spectra, normalized spectra as a divisor and dual wavelengths. A quaternary mixture of drotaverine (DRO), caffeine (CAF), paracetamol (PCT) and para-aminophenol (PAP) was taken as an example for application of the proposed techniques without any separation steps. The adopted techniques adopted of successive and progressive steps manipulating zero /or ratio /or derivative spectra. The proposed techniques includes eight novel and simple methods namely direct spectrophotometry after applying derivative transformation (DT) via multiplying by a decoding spectrum, spectrum subtraction (SS), advanced absorbance subtraction (AAS), advanced amplitude modulation (AAM), simultaneous derivative ratio (S^{1}DD), advanced ratio difference (ARD), induced ratio difference (IRD) and finally double divisor–ratio difference-dual wavelength (DD-RD-DW) methods.

### Results

The proposed methods were assessed by analyzing synthetic mixtures of the studied drugs. They were also successfully applied to commercial pharmaceutical formulations without interference from other dosage form additives. The methods were validated according to the ICH guidelines, accuracy, precision, repeatability, were found to be within the acceptable limits.

### Conclusion

The proposed procedures are accurate, simple and reproducible and yet economic. They are also sensitive and selective and could be used for routine analysis of complex most of the binary, ternary and quaternary mixtures and even more complex mixtures.

### Keywords

Derivative transformation Advanced ratio difference Induced ratio difference normalized spectra Isosbestic point Dual wave length## Background

Drotaverine (DRO) hydrochloride, 1-[(3,4-Diethoxy phenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride [1, 2] is non-anticholinergic antispasmodic drug.

Caffeine (CAF) 1,3,7-Trimethylpurine-2,6-Dione, is an adenosine receptor antagonist and adenosine 3′,5′cyclic monophosphate (cAMP) phosphodiesterase inhibitor, thus levels of cAMP increase in cells following treatment with caffeine [2, 3].

Paracetamol (PCT) *N*-(4-hydroxyphenyl) acetamide, also known as acetaminophen PAR is widely used as analgesic and antipyretic for the relief of fever, headaches and minor pains. It is a major ingredient in numerous cold and flu remedies [4, 5].

The analysis of mixtures containing DRO, CAF and PCT was described in few analytical reports. These reports proposed spectrophotometric [8, 9], TLC [9] and high performance liquid chromatography (HPLC) [8, 10, 11].

While literature survey reveals that no methods have been reported for the simultaneous determination of the four components under study.

The aim of this work was to develop novel spectrophotometric methods based on smart original mathematical techniques for resolving the quaternary mixture of DRO, CAF, PCT and PAP with spectral interfering problems.

## Theoretical background

Derivative transformation [12], spectrum subtraction [13], amplitude factor [14], advanced absorbance subtraction method (AAS) [15], advanced amplitude modulation method (AAM) [15] and simultaneous derivative ratio (S^{1}DD) [16] are well developed method that were successfully adopted for resolution of overlapped spectra of binary mixtures.

For simultaneous determination of ternary mixtures two novel methods were newly proposed namely ratio difference-isosbestic points (RD-ISO) and induced ratio difference (IRD).

Ratio difference-isosbestic points (RD-ISO) is considered as an extension to ratio difference method [17]. The method requires the presence of two isosbestic points (λ_{iso1} and λ_{iso2}) between two drugs for its successful application as discussed briefly.

If a ternary mixture X, Y and Z where (X and Y) shows two isoabsorptive points, Z can be determined by dividing the spectrum of the ternary mixture by normalized spectrum of X′.

The ratio spectra obtained using X′ as a divisor generated a constant value of its concentration along the whole spectra.

Suppose the amplitudes of the ratio spectra of the ternary mixture at the two selected wavelength (λ_{iso1} and λ_{iso2} between X and Y) are P_{1} and P_{2}, respectively, then;

The concentration of Z is calculated using the regression equation representing the linear correlation between the differences of ratio spectra amplitudes at the two selected wavelengths to the corresponding concentrations of drug (Z).

While IRD method is a combination between induced dualwavelength [18] and amplitude modulation theory. All what it need is the extension of one of the three drugs over the other two as summarized briefly.

The ratio spectra obtained using the normalized spectrum of the more extended component Z′ as a divisor generated a constant value of its concentration along the whole spectra that can be measured from the extended region parallel to the X axis.

The constant value of Z was then subtracted from the total ratio spectrum of the ternary mixture to obtain the ratio spectra of the other two components X and Y.

For determination of X, two wave lengths were selected in the ratio spectra of the resolved binary mixture. A remarkable amplitude difference between the two selected wavelengths in the ratio spectra of pure X should be present. To cancel the contribution of Y at the two selected wavelengths upon obtaining the ratio difference, the equality factor of pure ratio spectra of Y at these wavelengths (F_{Y}) is calculated.

_{Y}

_{Y}P

_{Y2}will be cancelled:

Equation (8) indicated that the amplitude difference of the ratio spectra of the resolved binary mixture X, Y is dependent only on X and independent on Y.

The concentration of Y is calculated using the same procedure after calculating the equality factor of pure X (F_{X}) at the two chosen wavelengths for Y.

Finally another novel method for simultaneous determination of quaternary mixtures was proposed and named double divisor-ratio difference-dual wave length (DD-RD-DW). It considered as one of the new applications of double divisor [19] and an extension to the double divisor-ratio difference method (DD-RD) [20] by coupling it with dual wavelength method.

For the determination of concentration of component of interest by the DD-RD-DW method, the component of interest shows a significant amplitude difference at two selected wavelengths λ_{1} and λ_{2} where the two interfering substances used as double divisor give constant amplitude as while the third one shows the same amplitude values at these two selected wavelengths.

This can be summarized in the following equations.

If we have a mixture of four drugs (X, Y, Z and W), dividing the spectrum of the quaternary mixture by the sum of the normalized spectra of Z and W (Z′ + W′) as a divisor, a constant value is generated in a certain region of wavelengths.

Suppose the amplitudes at the two selected wavelength are P_{1} and P_{2} at λ_{1} and λ_{2} (where Y has the same amplitude), respectively, then;

The concentration of X is calculated using the regression equation representing the linear correlation between the differences of ratio spectra amplitude at the two selected wavelengths to the corresponding concentrations of drug (X).

## Experimental

### Reagents and chemicals

- (a)
Pure samples—drotaverine (DRO) was kindly supplied by Alexandria Pharmaceuticals and Chemical Industries, Alexandria, Egypt. CAF and PCT were kindly supplied by Minapharm Pharmaceutical Company, Cairo, Egypt. Para-aminophenol was purchased from Sigma Aldrich, Germany. The purities were found to be 100.25 ± 0.39, 99.56 ± 0.59, 99.98 ± 0.25 and 99.99 ± 0.39 for DRO, CAF, PCT and PAP respectively.

- (b)
Market sample—

*Petro*tablets, labelled to contain 40 mg (DRO)/400 mg (PCT)/60 mg (CAF),*Soumadril Compound*tablets labelled to contain 200 mg Carisopradol (CAR)/160 mg (PCT)/32 mg (CAF) and*Panadol Extra*tablets labelled to contain 500 mg (PCT)/65 mg (CAF), were purchased from the Egyptian market. - (c)
Solvents—Spectroscopic analytical grade methanol (S.d.fine-chem limited-Mumbai).

- (d)
Stock standard solutions—(1 mg/mL) stock solution of each of DRO, CAF, PCT and PAP in methanol were prepared. The prepared solutions were found to be stable without any degradation when stored in the dark in the refrigerator at 4° C for 1 week except for PAP which should be freshly prepared.

- (e)
Working standard solutions—(50 μg/mL) working solutions for DRO, CAF, PCT and PAP were prepared from (1 mg/mL) stock solutions by appropriate dilutions with methanol.

### Apparatus

Spectrophotometric measurements were carried out on JASCO V-630 BIO Double-beam UV–Vis spectrophotometer (S/N C367961148), using 1.00 cm quartz cells. Scans were carried out in the range from 200 to 400 nm at 0.1 nm intervals. Spectra Manager II software was used.

### Procedures

#### Construction of calibration graphs

Aliquots equivalent to 10–260 μg DRO, 15–260 μg CAF, 10–240 μg PCT and 10–300 μg PAP were accurately transferred from their working standard solutions into four separate series of 10-mL volumetric flasks then completed to volume with the same solvent. The spectra of the prepared standard solutions were scanned from 200 to 400 nm and stored in the computer against methanol as a blank.

##### For DRO

A calibration graph was constructed relating the absorbance of zero order spectra (D^{0}) of DRO at 228.5 nm versus the corresponding concentrations.

The stored (D^{0}) spectra of DRO were divided by (a) the normalized spectrum of CAF, (b) the normalized spectrum of DRO, (c) sum of normalized spectrum of CAF and PAP, separately. Calibration graphs were constructed by plotting (a) the difference between the amplitudes at [263.6 and 291.8 nm], (b) the constant values measured from 310–400 nm, (c) the difference between the amplitudes at [315 and 336 nm] versus the corresponding DRO concentrations, respectively.

##### For CAF

Two calibration graphs were constructed using the zero order spectra (D^{0}). The first one related the absorbance at 263.6 nm versus the corresponding CAF concentrations. While the second one related the difference between the absorbance at 231.5 and 263.6 nm versus the absorbance at 263.6 nm.

The (D^{0}) spectra of CAF were divided by the normalized spectrum of PCT, and then two calibration graphs were constructed. The first was plotted between the amplitudes difference at [240 and 263.6 nm] versus amplitudes at 263.6 nm where as the second graph between the amplitudes difference at [233.8 and 273.7 nm] versus the corresponding CAF concentrations.

The stored (D^{0}) spectra of CAF were also divided by the normalized spectrum of DRO and the obtained ratio spectra were manipulate for construction of another 2 calibration graphs. A graph was directly constructed between the amplitude difference at 265 and 295 nm multiplied by (5.58) versus the corresponding CAF concentrations and the regression equations were computed. The first derivative of the above ratio spectra was then recorded using scaling factor = 1 and ∆λ = 8 and a calibration graph between the amplitude at 219 nm versus the corresponding concentrations of CAF was constructed.

##### For PCT

A calibration graph was constructed relating the absorbance of zero order spectra (D^{0}) of CAF or PCT at 263.6 nm versus the corresponding concentrations.

The stored (D^{0}) spectra of PCT were divided by (a) the normalized spectrum of CAF, (b) normalized spectrum of DRO and (c) the sum of normalized spectrum of DRO and CAF, separately. Three calibration graphs were constructed by plotting (a) the amplitude differences between 219.2 and 252 nm, (b) amplitude differences between 257 and 230 nm multiplied by (4.73), (c) amplitude differences between 261.2 and 277.2 nm versus the corresponding PCT concentrations, respectively.

##### For PAP

The zero order spectra (D^{0}) of PAP were scanned and manipulated to obtain two calibration graphs. Firstly, they were divided by the sum of normalized spectrum of DRO and CAF, to construct a calibration graph was constructed between the amplitude differences at 311 and 318 nm versus the corresponding PAP concentrations. Then their first derivative spectra (D^{1}) were recorded using scaling factor = 10 and ∆λ = 8 and a calibration graph was constructed relating the amplitude of the obtained (D^{1}) spectra of PAP at 314.5 nm versus the corresponding concentrations.

#### Application to laboratory prepared mixtures

Into a series of 10 mL volumetric flask, accurate aliquots of DRO, CAF, PCT and PAP were transferred from their working standard solutions to prepare five mixtures containing different ratios of the cited drugs. The volumes were completed with methanol.

Each drug in the quaternary mixture can be determined and analysed by more than one method using different approaches.

DRO was determined by four different methods; direct spectrophotometric method after derivative transformation, ratio difference-isosbestic points, induced ratio difference and double divisor-ratio difference-dual wavelength;

CAF was determined by five different methods; advanced absorbance subtraction, advanced amplitude modulation, simultaneous derivative ratio, ratio difference-isosbestic points and induced ratio difference.

PCT was determined using six different methods; advanced absorbance subtraction, advanced amplitude modulation, simultaneous derivative ratio, ratio difference-isosbestic points, induced ratio difference and double divisor-ratio difference-dual wavelength.

While PAP was determined adopting two methods; first derivative spectrophotometric method and double divisor-ratio difference-dual wavelength.

#### Application to pharmaceutical dosage form

Ten tablets of each of Petro^{®}, Soumadril Compound^{®} and Panadol Extra^{®} formulations were accurately weighed, finely powdered and homogenously mixed. A portion of the powder equivalent to 5 mg PCT were separately weighed from Petro^{®} (A), Soumadril Compound^{®} (B) and Panadol Extra^{®} (C), respectively and dissolved in methanol by shaking in ultrasonic bath for about 30 min. The solution was filtered into a 100 mL measuring flask and the volume was completed with the same solvent. 2 mL were accurately transferred from the above prepared solutions of formulations (A, B) and 4 mL were accurately transferred from the solution of formulation (C), to three separate 10-mL volumetric flasks. The concentration of each drug was calculated using its specified methods. When carrying out the standard addition technique, different known concentrations of pure standard of each drug were added to the pharmaceutical dosage form before proceeding in the previously mentioned procedure.

## Results and discussion

^{0}) of DRO by dividing the spectrum of the quaternary mixture by the first derivative of normalized spectrum of DRO (d/dλ) [a

_{DRO}], and then the constant generated in the region 360–380 nm was multiplied by the normalized spectrum of DRO [a

_{DRO}] where the absorbance of DRO can be measured at its 228.5 nm (λ

_{max}) giving maximum sensitivity and minimum error as shown in Fig. 4.

Also when the generated constant was multiplied by the first derivative of normalized spectrum of DRO used as divisor, the (D^{1}) spectrum of DRO in the mixture was obtained and then subtracted from the total (D^{1}) of the quaternary mixture via spectrum subtraction technique the spectrum of the first derivative of the resolved ternary mixture of CAF, PCT and PAP was obtained and PAP was determined by measuring the peak amplitude at 314.3 nm where CAF and PAP showed no contribution as shown in Fig. 3. Similarly, derivative transformation technique was adopted to obtain the D^{0} of PAP by dividing the spectrum of the above resolved ternary mixture by the first derivative of normalized spectrum of PAP (d/dλ) [a_{PAP}], and then the constant generated in the region 310–330 nm was multiplied by the normalized spectrum of PAP [a_{PAP}]. The obtained D^{0} of PAP was successively subtracted from the D^{0} spectrum of the resolved ternary mixture to get the D^{0} spectrum of binary mixture of CAF and PCT.

Three different novel, simple and accurate methods were adopted for simultaneous determination of CAF and PCT in presence of each other either in bulk, in different dosage forms as binary mixture and in presence of other components after their resolutions.

### Advanced absorbance subtraction

The absorption spectra of CAF and PCT are severely overlapped in the wavelength region of 200–300 nm and intersect at 3 isoabsorptive point 226.9, 263.6 and 292 nm where the mixture of the drugs acts as a single component and give the same absorbance value as pure drug.

The absorption spectra of the standard solutions of CAF with different concentrations were recorded in the wavelength range of 200–400 nm. Two wavelengths are selected (λ_{iso} of CAF 263.6 nm and λ_{2} = 231.5 nm) where PCT shows equal absorbance at these wavelengths. The absorbance difference ∆A (A_{iso} – A_{231.5}) between two selected wavelengths on the mixture spectra is directly proportional to the concentration of CAF; while for PCT the absorbance difference inherently equals to zero. A calibration graph is constructed for pure CAF representing the relationship between (A_{iso} – A_{2}) and A_{iso} and a regression equation was computed.

By substituting the absorbance difference ∆A (A_{iso} – A_{2}) between the two selected wavelengths of the mixture spectrum in the above equation, the absorbance A_{postulated} corresponding to the absorbance of CAF only at A_{iso} was obtained.

Subtracting the postulated absorbance of CAF at A_{iso} from the practically recorded absorbance [A_{Recorded}] at A_{iso} to get that corresponding to PCT.

The concentrations of CAF and PCT were calculated using the corresponding unified regression equation (obtained by plotting the absorbance of the zero order spectra of CAF or PCT at λ_{iso} 263.6 nm against the corresponding concentrations).

### Advanced amplitude modulation method (AAM)

_{CAF}= a

_{PCT}) which is retained at the same place in the ratio spectrum of CAF using the normalized spectrum of PCT as a divisor (Fig. 6a).

At first a regression equation was formulated representing the linear relationship between the amplitudes difference of different pure CAF concentrations at (263.6–240 nm) versus its corresponding amplitude 263.6 nm.

The AAM method was applied by dividing the spectrum of the binary mixture by the normalized divisor of PCT to obtain the ratio spectra (Fig. 6b). The amplitudes difference of the obtained ratio spectrum at 263.6 nm (λ_{iso}) and 240 nm were recorded (∆Pm). And by substituting in the above regression equation previously formulated postulated amplitude of CAF alone at 263.6 nm (λ_{iso}).

Subtracting the postulated amplitude of CAF at λ_{iso} from the practically recorded amplitude [P_{Recorded}] of the binary mixture at λ_{iso} we get that corresponding to PCT.

The advantage of this method over the advanced absorbance subtraction method is the complete cancelling of the interfering component in the form of constant where the difference at any two points along its ratio spectrum will be equal to zero. So there is no need for critical selection of wavelengths which leads to highly reproducible and robust results.

### Simultaneous derivative ratio

Salinas et al. [21] developed derivative ratio spectrophotometry (^{1}DD) method to remove the interference of one component and to determine the other. This method was then modulated to be simultaneous by coupling with amplitude modulation theory to generate simultaneous derivative ratio method (S^{1}DD) [16]. In S^{1}DD after division by the normalized spectra of PCT and before the derivatization step took place, the amplitude at isoabsorptive point (263.6 nm) was determined representing the actually concentration of CAF and/or PCT. Then derivative of these ratio spectra was obtained to remove the constant generated of PCT concentration in the division spectrum.

_{iso}263.6 nm) recorded before derivatization.

### For simultaneous determination of ternary mixture

#### Ratio difference-isosbestic points

Then the difference between the amplitudes at the two selected isosbestic points between CAF and PCT (263.6 and 291.8 nm) was directly proportional to DRO concentration only.

For determination of PCT, the difference between the amplitude of the above ratio spectra obtained after dividing the spectrum of the ternary mixture by the normalized spectrum of CAF at the two selected isosbestic points (219.2 and 252 nm) between CAF and DRO was corresponding to PCT concentration only as shown in Fig. 9a.

The same procedures were applied for determination of CAF where the absorption spectrum of the mixture was divided by the absorption spectrum of the normalized spectra of PCT as divisor and the difference between the amplitude at the two selected isosbestic points (233.8 and 273.7 nm) between DRO and PCT was corresponding to CAF concentration only as shown in Fig. 9b.

#### Induced ratio difference method

By screening the ratio spectra of pure CAF divided by the normalized spectra of DRO, two wavelengths were selected, 265 and 295 nm, where 265 nm showed the maximum peak in order to obtain maximum sensitivity. To cancel the contribution of PCT at both selected wavelengths, induced dual wave length method was adopted by calculating an equality factor for pure PCT at two selected wave lengths of CAF \(\left( {{\text{F}} \; = \; \left[ {{\text{P}}_{ 2 6 5} /{\text{P}}_{ 2 9 5} } \right] \; = \; 5. 5 8} \right)\) as shown in Fig. 10b.

In order to determine of PCT, the same procedures were applied as described for CAF. The two selected wavelengths were 257 nm (maximum peak amplitude) and 230 nm. The factor that equalize the amplitude of CAF at the selected wavelengths was calculated \(\left( {{\text{F}}\, = \;\left[ {{\text{P}}_{ 2 5 7} /{\text{P}}_{ 2 30} } \right] \; = \; 4. 7 3} \right)\).

### For simultaneous determination of quaternary mixture

#### Double divisor-ratio difference-dual wave length

For the successful application of the proposed method, it is a must to obtain a constant region in the ratio spectra resulted after dividing the total spectrum of any two drugs by the sum of their normalized spectra.

The method failed in determination of CAF. The main disadvantage of this method is the restriction in the choice of the selected wavelengths which are restricted to those wavelengths with constant absorbance of the interfering substance.

The proposed spectrophotometric methods were compared to a recently reported HPLC method [10] in which a separation was achieved on a C_{18} column (250 mm × 4.6 mm, 5 μm particle size), using methanol and 0.02 M phosphate buffer, pH 4.0 (50:50, v/v) as a mobile phase and UV detection at 220 nm. The chromatographic method showed better sensitivity where concentrations up to 0.5 µg/mL of each of DRO, CAF and PCT could be quantified. While the proposed novel spectrophotometric methods showed wider range. In addition the presented methods were capable to determine the concentration of PAP which is the main degradation products and synthetic impurity of PCT and thus could be considered as stability indicating methods. Also it needs no tedious conditions optimization as that required for the chromatographic method. The proposed spectrophotometric methods are also considered to be fast and time saving where the analysis of the quaternary or the ternary mixture takes few seconds once calibration graphs were constructed and regression equations are computed where all the reported chromatographic techniques needs at least 10 min in a single run to resolve the ternary mixture.

## Method validation

Assay parameters and method validation obtained by applying the proposed spectrophotometric methods for determination of DRO, CAF, PCT and PAP

Parameters | DRO | CAF | |||||||
---|---|---|---|---|---|---|---|---|---|

D | RD-Iso | IRD | DD-RD-DW | AAS | AAM | S | RD-Iso | IRD | |

Linearity (µg/mL) | 1–26 | 1.5–26 | |||||||

Slope | 0.0722 | 1.4648 | 1.0018 | 0.3179 | 0.0525 | 0.9961 | 0.5027 | 2.7068 | 1.92333 |

Intercept | 0.0036 | 0.0727 | 0.0036 | 0.0158 | −0.0005 | 0.0091 | −0.0008 | −0.0043 | −0.003 |

Correlation coefficient (r) | 1.0000 | 1.0000 | 1.0000 | 0.9999 | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 1.0000 |

Accuracy | 99.74 ± 0.40 | 99.67 ± 0.41 | 100.04 ± 0.29 | 100.77 ± 0.37 | 100.05 ± 0.14 | 100.25 ± 0.02 | 99.99 ± 0.01 | 99.96 ± 0.02 | 100.08 ± 0.02 |

RSD% | 0.249 | 0.248 | 0.105 | 0.398 | 0.110 | 0.115 | 0.187 | 0.177 | 0.110 |

RSD% | 0.317 | 0.315 | 0.186 | 0.372 | 0.205 | 0.207 | 0.223 | 0.231 | 0.211 |

Parameters | PCT | PAP | |||||||
---|---|---|---|---|---|---|---|---|---|

AAS | AAM | S | RD-Iso | IRD | DD-RD-DW | D | DD-RD-DW | ||

Linearity (µg/mL) | 1–24 | 1–30 | |||||||

Slope | 0.0525 | 0.9961 | 0.9961 | 3.6059 | 1.9062 | 0.945 | 0.0213 | 1.8265 | |

Intercept | 0.0005 | 0.0091 | 0.0091 | 0.0331 | 0.0175 | 0.0087 | 0.0010 | 0.0886 | |

Correlation coefficient (r) | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 0.9999 | 0.9999 | 0.9999 | |

Accuracy | 100.15 ± 0.31 | 100.30 ± 0.20 | 99.97 ± 0.25 | 100.01 ± 0.17 | 100.20 ± 0.21 | 99.98 ± 0.19 | 101.81 ± 0.40 | 100.146 ± 0.39 | |

RSD% | 0.380 | 0.315 | 0.382 | 0.279 | 0.201 | 0.374 | 0.727 | 0.732 | |

RSD% | 0.388 | 0.372 | 0.324 | 0.286 | 0.228 | 0.293 | 0.857 | 0.860 |

Determination of DRO, CAF, and PCT and PAP in laboratory prepared mixtures and pharmaceutical dosage forms by the proposed methods and results obtained by standard addition technique

Concentration (µg/mL) | Recovery% | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|

Lab prepared mix. | DRO | CAF | ||||||||||

DRO | CAF | PCT | PAP | D | RD-Iso | IRD | DD-RD-DW | AAS | AAM | S | RD-Iso | IRD |

2 | 3 | 20 | 2 | 101.24 | 98.78 | 100.95 | 101.25 | 99.46 | 100.35 | 100.27 | 100.22 | 100.27 |

10 | 10 | 10 | 1 | 98.24 | 99.75 | 99.33 | 98.24 | 99.65 | 100.17 | 99.98 | 99.97 | 99.98 |

6 | 12 | 6 | 6 | 99.42 | 99.41 | 99.87 | 99.42 | 99.94 | 100.43 | 100.23 | 100.22 | 100.24 |

20 | 8 | 4 | 4 | 100.13 | 100.05 | 99.96 | 100.14 | 99.62 | 100.18 | 100.00 | 99.98 | 100.01 |

12 | 20 | 8 | 2 | 99.83 | 99.82 | 99.84 | 99.84 | 99.78 | 100.22 | 100.00 | 100.01 | 100.00 |

0 | 2 | 10 | 1 | 99.97 | 99.97 | 100.19 | 101.20 | 100.15 | ||||

0 | 2.6 | 20 | 2 | 100.07 | 99.89 | 100.21 | 99.67 | 100.20 | ||||

Mean ± SD | 99.77 ± 1.09 | 99.56 ± 0.49 | 99.99 ± 0.53 | 99.78 ± 1.09 | 99.78 ± 0.21 | 100.17 ± 0.19 | 100.12 ±0.12 | 100.20 ± 0.52 | 100.12 ± 0.12 |

Concentration (µg/mL) | Recovery% | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|

Lab prepared mix. | PCT | PAP | |||||||||

DRO | CAF | PCT | PAP | AAS | AAM | S | RD-Iso | IRD | DD-RD-DW | D | DD-RD-DW |

2 | 3 | 20 | 2 | 100.11 | 101.21 | 99.80 | 100.21 | 100.12 | 100.12 | 99.20 | 99.85 |

10 | 10 | 10 | 1 | 100.07 | 100.65 | 100.02 | 100.26 | 100.07 | 100.08 | 98.66 | 99.61 |

6 | 12 | 6 | 6 | 100.33 | 100.92 | 100.59 | 100.65 | 100.34 | 100.34 | 102.38 | 100.68 |

20 | 8 | 4 | 4 | 99.84 | 100.37 | 100.25 | 100.39 | 99.94 | 99.94 | 98.80 | 98.80 |

12 | 20 | 8 | 2 | 100.18 | 99.98 | 100.46 | 100.35 | 100.12 | 100.12 | 99.65 | 98.00 |

0 | 2 | 10 | 1 | 100.21 | 100.89 | 100.45 | 99.65 | 100.31 | 99.89 | 99.42 | 99.38 |

0 | 2.6 | 20 | 2 | 99.95 | 99.91 | 99.97 | 99.82 | 99.76 | 100.32 | 98.02 | 100.75 |

Mean ± SD | 100.10 ± 0.16 | 100.56 ± 0.49 | 100.22 ± 0.29 | 100.19 ± 0.34 | 100.09 ± 0.20 | 100.11 ± 0.17 | 99.45 ± 1.40 | 99.57 ± 0.99 |

Determination of DRO, CAF, and PCT and PAP in pharmaceutical dosage forms by the proposed methods and results obtained by standard addition technique

Pharmaceutical dosage form | Recovery% | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

DRO | CAF | PCT | |||||||||||||

D | RD-Iso | IRD | DD-RD-DW | AAS | AAM | S | RD-Iso | IRD | AAS | AAM | S | RD-Iso | IRD | DD-RD-DW | |

Petro 40(DRO)/400(PCT)/60 (CAF), mean ± SD | 99.79 ± 0.48 | 99.93 ± 0.57 | 99.91 ± 0.30 | 99.80 ± 0.49 | 99.01 ± 0.81 | 99.90 ± 0.78 | 99.82 ± 0.65 | 99.72 ± 0.79 | 99.83 ± 0.70 | 100.14 ± 0.21 | 100.18 ± 0.58 | 99.63 ± 0.40 | 100.08 ± 0.45 | 100.19 ± 0.16 | 100.05 ± 0.27 |

Standard addition, mean ± SD | 99.63 ± 0.22 | 99.70 ± 0.35 | 99.27 ± 0.16 | 99.57 ± 0.44 | 101.61 ± 0.97 | 100.98 ± 0.35 | 100.32 ± 0.21 | 99.51 ± 1.80 | 98.98 ± 1.66 | 99.96 ± 1.71 | 99.85 ± 0.05 | 100.78 ± 1.30 | 100.84 ± 0.64 | 100.58 ± 0.59 | 100.59 ± 0.72 |

Soumadril Comp. 200 (CAR)/160 (PCT)/32 (CAF), mean ± SD | 100.76 ± 0.49 | 100.02 ± 0.51 | 100.01 ± 0.51 | 99.86 ± 0.46 | 100.01 ± 0.41 | 100.20 ± 0.62 | 99.52 ± 0.43 | 100.58 ± 0.61 | 101.03 ± 0.53 | 100.85 ± 0.47 | 100.75 ± 0.62 | ||||

Standard addition, mean ± SD | 101.08 ± 0.76 | 101.23 ± 0.43 | 100.88 ± 0.59 | 99.63 ± 0.85 | 99.57 ± 1.21 | 100.48 ± 1.35 | 99.30 ± 0.32 | 100.64 ± 0.60 | 100.77 ± 0.55 | 100. 81 ± 0.68 | 100.47 ± 0.85 | ||||

Panadol Extra 500 (PCT)/65 (CAF), mean ± SD | 100.55 ± 0.36 | 100.05 ± 0.39 | 99.76 ± 0.78 | 99.68 ± 0.73 | 100.08 ± 0.31 | 100.14 ± 0.58 | 100.01 ± 0.82 | 100.22 ± 0.30 | 100.27 ± 0.28 | 100.32 ± 0.71 | 100.54 ± 0.25 | ||||

Standard addition, mean ± SD | 100.38 ± 0.55 | 100.79 ± 0.84 | 100.54 ± 0.57 | 99.88 ± 0.47 | 100.17 ± 1.35 | 100.24 ± 0.82 | 99.57 ± 0.54 | 99.86 ± 0.57 | 100.34 ± 0.68 | 100. 08 ± 0.78 | 100.29 ± 0.61 |

## Statistical analysis

*t*and F values were less than the theoretical ones indicating that there was no significant difference between them with respect to accuracy and precision.

Values | DRO | CAF | PCT | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

Proposed methods | Reported method [23] | Proposed methods | Official method [24] | Proposed methods | Official method [25] | |||||||||||||

D | RD-Iso | IRD | DD-RD-DW | AAS | AAM | S | RD-Iso | IRD | AAS | AAM | S | RD-Iso | IRD | DD-RD-DW | ||||

Mean | 99.79 | 99.93 | 99.91 | 99.80 | 100.25 | 99.01 | 99.90 | 99.82 | 99.72 | 99.83 | 99.56 | 100.14 | 100.18 | 99.63 | 100.08 | 100.19 | 100.05 | 99.98 |

SD | 0.48 | 0.57 | 0.30 | 0.49 | 0.39 | 0.81 | 0.78 | 0.65 | 0.79 | 0.70 | 0.59 | 0.21 | 0.58 | 0.40 | 0.45 | 0.16 | 0.27 | 0.25 |

RSD% | 0.481 | 0.570 | 0.300 | 0.490 | 0.389 | 0.818 | 0.780 | 0.651 | 0.792 | 0.701 | 0.592 | 2.097 | 0.578 | 0.402 | 0.449 | 0.159 | 0.269 | 0.250 |

n | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |

Variance | 0.2304 | 0.324 | 0.0900 | 0.240 | 0.1521 | 0.6561 | 0.6084 | 0.4225 | 0.6241 | 0.49 | 0.3481 | 0.0441 | 0.3364 | 0.1600 | 0.2025 | 0.0256 | 0.0729 | 0.0625 |

Student’s t test | 1.663 | 1.036 | 0.1609 | 1.607 | 1.227 | 0.7774 | 0.6623 | 0.3629 | 0.5281 | 1.096 | 0.7081 | 1.659 | 0.4344 | 0.1523 | 0.4254 | |||

F value | 1.515 | 2.136 | 1.690 | 1.579 | 1.885 | 1.748 | 1.214 | 1.793 | 1.408 | 1.417 | 5.382 | 2.560 | 3.240 | 2.441 | 1.166 |

## Conclusions

In this work more than eight novel and smart spectrophotometric methods were developed and validated for the resolution of the quaternary mixtures either successively or progressively. Drotaverine, caffeine, paracetamol and para-aminophenol, the main degradation product and synthetic impurity of Paracetamol quaternary mixture was taken as a model for application of the proposed methods.

It could be concluded that the proposed procedures are accurate, simple and reproducible and yet economic. They are also sensitive and selective and could be used for routine analysis of complex most of the binary, ternary and quaternary mixtures and even more complex mixtures. The proposed methods also showed the significance of isoabsorptive point, normalized spectra as divisors and dual wavelengths as powerful tools that could either be used alone or in combination with each other for the resolution of severely overlapped spectra without preliminary separation.

## Declarations

### Authors’ contributions

EHM collected the data, wrote the manuscript, made the practical work in the lab, and put the theoretical background. HML put the theoretical background, revised the manuscript, revised the results, and collected the data. MAH revised the manuscript and the data, collected the data, and put the theoretical background. SHM revised the manuscript, revised the data and the figures, and collected the data. All authors read and approved the final manuscript.

### Competing interests

The authors declare that they have no competing interests.

### Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

**Open Access**This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

## Authors’ Affiliations

## References

- Budavari S (2003) The merck index, 13th edn. Merck and Co Inc, Whitehouse StationGoogle Scholar
- Sweetman SC (2009) Martindale: the complete drug reference, 33rd edn. Pharmaceutical Press, LondonGoogle Scholar
- Shafer SH, Phelps SH, Williams CL (1998) Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors. Biochem Pharmacol 56:1229–1236View ArticleGoogle Scholar
- Fredholm BB, Battig K, Holmen J, Nehlig A, Zvatau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–88Google Scholar
- Gilman AC, Rall TW, Nies AS, Tayor P (2001) Goodman and Gilman’s the pharmacological basis of therapeutics, 10th edn. Pergamon Press, New YorkGoogle Scholar
- Nemeth T, Jankovics P, Nemeth-Palotas J, Koszegi-Szalai H (2008) Determination of paracetamol and its main impurity 4-aminophenol in analgesic preparations by micellar electrokinetic chromatography. J Pharm Biomed Anal 47:746–749View ArticleGoogle Scholar
- Dejaegher B, Bloomfield MS, Smeyers-Verbeke J, Vander Heyden Y (2008) Validation of a flourimetric assay for 4-aminophenol in paracetamol formulations. Talanta 75:258–265View ArticleGoogle Scholar
- El-Gindy A, Emara S, Shaaban H (2010) Validation and application of chemometrics-assisted spectrophotometry and liquid chromatography for simultaneous determination of two ternary mixtures containing drotaverine hydrochloride. J AOAC Int 93:536–548Google Scholar
- Metwally FH, El-Saharty YS, Refaat M, El-Khateeb SZ (2007) Application of derivative, derivative ratio, and multivariate spectral analysis and thin-layer chromatography–densitometry for determination of a ternary mixture containing drotaverine hydrochloride, caffeine, and paracetamol. J AOAC Int 90:391–404Google Scholar
- Belal FF, Sharaf El-Din MK, Tolba MM, Elmansi H (2015) Determination of two ternary mixtures for migraine treatment using HPLC method with ultra violet detection. Sep Sci Tech 50:592–603View ArticleGoogle Scholar
- Issa YM, Hassoun ME, Zayed AG (2012) Simultaneous determination of paracetamol, caffeine, domperidone, ergotamine tartrate, propyphenazone, and drotaverine HCl by high performance liquid chromatography. J Liq Chromat Rel Tech 35:2148–2161Google Scholar
- Hegazy MA, Lotfy HM, Rezk MR, Omran YR (2015) Novel spectrophotometric determination of chloramphenicol and dexamethasone in the presence of non labeled interfering substances using univariate methods and multivariate regression model updating. Spectrochim Acta A Mol Biomol Spectrosc 140:600–613View ArticleGoogle Scholar
- Lotfy HM, Hegazy MA, Mowaka S, Mohamed EH (2015) Novel spectrophotometric methods for simultaneous determination of amlodipine, valsartan and hydrochlorothiazide in their ternary mixture. Spectrochim Acta A Mol Biomol Spectrosc 140:495–508View ArticleGoogle Scholar
- Lotfy HM, Tawakkol SM, Fahmy NM, Shehata MA (2013) Validated stability indicating spectrophotometric methods for the determination of lidocaine hydrochloride, calcium dobesilate, and dexamethasone acetate in their dosage forms. Anal Chem Lett 3:208–225View ArticleGoogle Scholar
- Lotfy HM, Hegazy MA, Rezk MR, Omran YR (2015) Comparative study of novel versus conventional two-wavelength spectrophotometric methods for analysis of spectrally overlapping binary mixture. Spectrochim Acta A Mol Biomol Spectrosc 148:328–337View ArticleGoogle Scholar
- Lamie NT, Yehia AM (2015) Development of normalized spectra manipulating spectrophotometric methods for simultaneous determination of dimenhydrinate and cinnarizine binary mixture. Spectrochim Acta A Mol Biomol Spectrosc 150:142–150View ArticleGoogle Scholar
- Lotfy HM, Hegazy MA (2013) Simultaneous determination of some cholesterol-lowering drugs in their binary mixture by novel spectrophotometric methods. Spectrochim Acta Part A Mol Biomol Spectrosc 113:107–114View ArticleGoogle Scholar
- Lotfy HM, Saleh SS, Hassan NY, Salem H (2015) Novel two wavelength spectrophotometric methods for simultaneous determination of binary mixtures with severely overlapping spectra. Spectrochim Acta A Mol Biomol Spectrosc 136:1786–1796View ArticleGoogle Scholar
- Dinç E (1999) The spectrophotometric multicomponent analysis of a ternary mixture of ascorbic acid, acetylsalicylic acid and paracetamol by the double divisor-ratio spectra derivative and ratio spectra-zero crossing methods. Talanta 48:1145–1157View ArticleGoogle Scholar
- Hegazy MA, Eissa MS, Abd El-Sattar OI, Abd El-Kawy MM (2014) Determination of a novel ACE inhibitor in the presence of alkaline and oxidative degradation products using smart spectrophotometric and chemometric methods. J Pharm Anal 4:132–143View ArticleGoogle Scholar
- Salinas F, Nevado JJ, Mansilla AE (1990) A new spectrophotometric method for quantitative multicomponent analysis resolution of mixtures of salicylic and salicyluric acids. Talanta 37:347–351View ArticleGoogle Scholar
- International conference on harmonization (ICH), Q2B: validation of analytical procedures: methodology, vol 62. US FDA, Federal Register (1997)Google Scholar
- Jain J, Patadia R, Vanparia D, Chauhan R, Shah S (2010) Dual wavelength spectrophotometric method for simultaneous estimation of drotaverine hydrochloride and aceclofenac in their combined tablet dosage form. Int J Pharm Pharm Sci 2:76–79Google Scholar
- British pharmacopoeia, vol. 11. Her Majesty’s Stationery Office, London (2003)Google Scholar
- The United States pharmacopeia, the national formulary: USP 29 NF 24 (2007)Google Scholar